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Background
Malignant lymphomas are classified based on morphology, immunophenotype, genetics
and clinical features. The pathological diagnosis is generally considered difficult and prone
to mistakes. Since non-random chromosomal translocations are specifically involved in
specific entities, their detection is an important adjunct for increasing the reliability of the
diagnosis. Recently, split-signal fluorescence in situ hybridization has become available as
a robust method to detect chromosomal breaks in paraffin-embedded formalin-fixed tis-
sues. A bright field approach would bring this technology within the reach of every
pathology laboratory.
Design and Methods
Our study was initiated to determine the consistency between chromogenic in situ
hybridization and fluorescence in situ hybridization, both using split-signal probes devel-
oped for the detection of chromosomal breaks. Five hundred and forty cases of 11 lym-
phoma entities and reactive, benign lymphoid tissues, collected from eight different
pathology laboratories, placed on 15 fluorescence in situ hybridization pre-stained tissue
microarray slides, were double stained for the chromogenic hybridization. For each core
morphology and actual signal were compared to the original fluorescence hybridization
results. In addition, hematoxylin background staining intensity and signal intensity of the
double-staining chromogenic in situ hybridization procedure were analyzed. 
Results
With respect to the presence or absence of chromosomal breaks, 97% concordance was
found between the results of the two techniques. Hematoxylin background staining inten-
sity and signal intensity were found to correspond. The overall morphology after double-
staining chromogenic in situ hybridization had decreased compared to the initial morphol-
ogy scored after split-signal fluorescence in situ hybridization staining.
Conclusions
We conclude that double-staining chromogenic in situ hybridization is equally reliable as
fluorescence in situ hybridization in detecting chromosomal breaks in lymphoid tissue.
Although differences in morphology, hematoxylin staining and chromogenic signal inten-
sity vary between the tumor entities none of the entities appeared more easy or difficult
to score.
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ABSTRACT
Introduction
The World Health Organization (WHO) has classified
about 40 different lymphoma entities that differ widely in
clinical behavior and therapy response. The diagnosis of
lymphomas is a complex process, which needs to take
into account clinical, morphological, immunophenotypic
and genetic features. As the therapeutic options for lym-
phoma patients increase, the need for a precise pathologi-
cal diagnosis and classification becomes more important.
It is known that different types of lymphoma are associat-
ed with non-random chromosomal translocations.1,2,3,4,5
The detection of these aberrations is, therefore, an impor-
tant step in the identification of specific lymphoma enti-
ties. Several techniques are now available to detect chro-
mosomal alterations. 
Cytogenetic analysis, based on banding techniques, pro-
vides an overview of all cytogenetic aberrations.
However, failed culturing of tumor cells, low mitotic
indices and the lack of fresh material often complicate the
use of this technology for routine diagnosis. Polymerase
chain reaction (PCR)-based methods have the advantage
of being sensitive and applicable in paraffin-embedded,
formalin-fixed tissues, but only for those rare cases in
which the chromosomal breaks involved in the transloca-
tion are clustered in a small area.6 In a recent review,7 it
was nicely outlined that fluorescence in situ hybridization
(FISH) has, over the last decade, become a firmly estab-
lished technique and the method of choice in routine clin-
ical practice. 
To detect a translocation in a tumor cell one can use
fusion probes [probes with different colors on different
chromosomes (usually two)] which, in the case of a
translocation, show a fusion signal.8 This procedure is fea-
sible when complete cells or nuclei can be evaluated as in
cytospins or preparations of isolated nuclei, but is more
difficult in tissue sections, in which many nuclei are cut
and/or overlap resulting in the presence of a complete sig-
nal in only a minority of cells, making interpretation cum-
bersome. In order to detect a chromosomal break reliably,
it is desirable to be able to analyze tissue sections for
translocations, since often only a minority of cells in a
biopsy are lymphoma cells making a direct comparison
with routine hematoxylin and eosin-stained tissue sec-
tions and immunostained slides important. Split-signal or
break-apart probes use differently colored probes on both
sides of a known breakpoint region, resulting in a fused
signal in normal cells, and two different single colors
when a chromosomal break occurs.9 This approach is
advantageous in tissue sections since each single colored
signal indicates a specific chromosomal break. 
Just recently, the Euro-FISH project, representing a con-
certed multicenter retrospective study in the field of lym-
phoma diagnosis on paraffin-embedded material, demon-
strated the robustness of a FISH protocol.10 In this study
we describe double-staining chromogenic in situ
hybridization (DuoCISH) as an alternative to split-signal
FISH in the diagnosis of lymphoma.
Design and Methods
Materials
Sixty-four split-signal FISH-stained tissue microarray (TMA)
slides, cut from four different TMA paraffin blocks, with each
block consisting of 36 cores, of paraffin-embedded, neutral-
buffered formalin-fixed biopsies were kindly provided by the
Euro-FISH consortium.10 Areas of tumor cells used to prepare the
TMA were specifically pre-analyzed and confirmed using hema-
toxylin and eosin-stained slides. Original TMA (from the Euro-
FISH program) were centrally prepared using punch needles of 1
mm.10 Eighteen months ago, the four different TMA were stained
with 16 different FISH probes (see Table 1) in eight European lab-
oratories (4 probes per laboratory resulting in 2 independent dupli-
cates per probe), analyzed and subsequently stored in the dark at
4°C and normal air pressure. Fifteen TMA, each stained with a dif-
ferent CISH-compatible FISH probe (with the lowest number of
lost cores per probe after FISH staining), were chosen for CISH
staining. In addition to these slides, one slide cut from TMA n. 3
(kindly provided by the Euro-FISH consortium), stored unstained
for the same period of time and under the same conditions as
described above, was freshly stained for BCL6-FISH and CISH.
Furthermore, a metaphase spread of B-lymphocytes from a
healthy donor, used during the Euro-FISH program to validate the
BCL6 FISH-probe,10 was re-used for DuoCISH staining. CISH-
stained slides were analyzed by bright-field microscopy.
The evaluation involved testing 15 different FISH probes on 11
different WHO lymphoma entities; diffuse large B-cell lymphoma,
mantle cell lymphoma, B-cell chronic lymphocytic leukemia/small
lymphocytic lymphoma, follicular lymphoma, gastric extranodal
marginal zone lymphoma (gastric MALT), splenic marginal zone
lymphoma, endemic and sporadic Burkitt’s lymphoma, lympho-
plasmacytic lymphoma, anaplastic large cell lymphoma, all ALK+,
and T-lymphoblastic lymphoma, supplemented with reactive tis-
sues (spleen, tonsil, lymph node and thymus). All entities were
evenly distributed over the TMA. 
Probes and fluorescence and chromogenic in situ
hybridization procedures
Eighteen months ago, four TMA were each stained with 16 dif-
ferent split-signal FISH probes The cut-off of the FISH probes is set
at 85%, as determined by counting studies for CE-marking using
FISH probes (unpublished data). Fifteen of these TMA (all FISH-
stained with different probes) were subsequently DuoCISH-
stained (Dako DuoCISH Kit, code no. SK108 and Dako
Hematoxylin code S3301, Dako Denmark A/S, Produktionsvej 42,
DK-2600 Glostrup, Denmark) and analyzed using bright field
microscopy.
Four different TMA were used, each containing three samples
of endemic Burkitt’s lymphoma, three anaplastic large cell lym-
phomas, three B-cell chronic lymphocytic leukemia/small lym-
phocytic lymphomas, four diffuse large B-cell lymphomas, three
follicular lymphomas, three lymphoplasmacytic lymphoma, three
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Table 1. Tissue microarrays used for DuoCISH that were previously split-signal
FISH-stained during the Euro-FISH project.
FISH probe
TMA1 PAX5 TCRAD TCL1
TMA2 ALK TCRG CCND1 MALT
TMA3 IGH TCRB MYC IGH BCL3
TMA4 BCL10 BCL2 IGL
gastric MALT lymphomas, three mantle cell lymphomas, three
splenic marginal zone lymphomas, three sporadic Burkitt’s lym-
phoma, three T-lymphoblastic lymphomas and two reactive
cases. The TMA were constructed using each tumor biopsy just
once.
Slides were manually stained according to the manufacturer's
manual. A microwave step (Whirlpool JT356, 6th Sense Steam
function, 10 min) was used instead of a water bath in the pretreat-
ment procedure (FISH procedure). The hybridizer, 240V, CE-IVD
S2451 was used for the pepsin digestion step, denaturation and
hybridization step, red and blue chromogenic incubation steps
and the counter stain step (FISH and CISH procedures). All previ-
ously split-signal FISH-stained slides had been stored in a dark
room at 4°C (normal air pressure). One slide, stored unstained at
4°C, was freshly BCL6-stained using the FISH protocol previously
described10 and subsequently DuoCISH-stained. 
The following FISH probes (with chromosomal localization),
serving as templates for DuoCISH-staining, were used:
BCL10(1p22); IGK(2p11); ALK(2p23); BCL6(3q27); TCRG(7p14);
TCRB(7q34); MYC(8q24); PAX5(9p13); CCND1(11q13);
TCRAD(14q11); TCL1(14q32); IGH(14q32); MALT1(18q21);
BCL2(18q21); BCL3(19q13); and IGL (22q11).
Data collection
The TMA signals were scored manually according to the
manufacturers’ guidelines. A signal was considered co-local-
ized (normal gene segment) if the red and blue signals (red and
green for FISH) co-localized or if one red signal and one blue
signal were separated by a distance equal to or less than two
times the diameter of one signal or if two signals of the same
size and color were separated by a distance equal to or less
than two times the diameter of one signal. The signals were
scored as a split signal (chromosomal break) if two signals of
different color were separated by a distance more than two
times the diameter of one signal (http://pri.dako.com/split-sig-
nal_flyer_interpreation_guide_20308.pdf). Tissue slides were
analyzed by microscopic detection without the aid of software.
Furthermore, data concerning morphology (good, intermediate,
poor/failure), hematoxylin staining intensity (good, acceptable,
weak, very weak, failure), signal intensity (strong, moderate,
weak, very weak, absent/failure) and actual score (normal = PP,
or abnormal = PPP/PB/PR/BR/PPR/PPB or any other combination
except PP or no score; with P= purple, B=blue and R=red) were
collected using a routine bright field microscope.
Results
During the EuroFISH protocol four TMA, each consist-
ing of 36 cores were prepared with 11 different WHO
lymphoma entities, supplemented with reactive benign
tissues. Out of the 64 TMA that were previously FISH
stained, 15 (each stained with a different FISH probe, see
Table 1) were selected for DuoCISH staining, resulting in
540 CISH-stained cores.
After DuoCISH staining cores were analyzed by bright
field microscopy and scored for morphology, hematoxylin
staining intensity and signal intensity and signal (split or
no split). Analysis of these slides was performed in a
blinded fashion without prior knowledge of the original
split-signal FISH scores or the diagnosis. 
A total of 540 cores were DuoCISH stained of which
105 could not be scored; half of these were on three TMA
(TMA n.2 stained with CCND1, 17 cases; TMA n. 2
stained with MALT, 19 cases and TMA n.3 stained with
MYC, 15 cases). On the other hand, 11 cores that could
not be scored in the Euro-FISH protocol were evaluable
using CISH. Cores lost during the FISH protocol or lost
during the DuoCISH procedure were not used for further
analysis. Morphology, hematoxylin staining intensity, sig-
nal intensity and diagnostic result after CISH staining
were analyzed per tumor entity. These data, except for
diagnostic results, are shown in Figure 1. The number of
cores of a specific entity with a specific score is represent-
ed as a percentage of the total number of cores of that
DuoCISH as an alternative to split-signal FISH
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Figure 1. Percentages per entity: (A) morphology, (B) background
staining intensity and (C) signal intensity. The number of cores per
entity with a specific score are shown as a percentage of the total
number of cores analyzed for that specific entity. 
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entity. Although slight differences were seen for morphol-
ogy (panel A), background staining (panel B) and signal
intensity (panel C), overall there were no relevant differ-
ences between entities.
To compare actual FISH and CISH scores of split signals,
only cores with readable signals were included, resulting
in 310 cores. All cores that, during FISH or DuoCISH,
were lost or received a designation of failure with respect
to the actual score were not used, resulting in eight cores
(2.6%) that were found to be differentially scored, mean-
ing that CISH data were inconsistent with the original
FISH-data for that particular core. However, these CISH
scores were consistent with the Euro-FISH-program inde-
pendent duplicate TMA (same TMA, different serial
coupe, stained and scored by a second laboratory), sug-
gesting that the interpretation of CISH is slightly better
than FISH in these cases. Two cores (0.7%), however,
were inconsistent with respect to both Euro-FISH dupli-
cates, resulting in overall consistency for 300 cores
(96.8%). Figure 2 shows a representative example of a
mantle cell lymphoma stained with a CCND1 split-signal
probe after split-signal FISH and DuoCISH.
Following DuoCISH staining, morphology was scored
and analyzed. Table 2 shows the overall numbers and per-
centages after FISH staining and, for the same TMA, after
DuoCISH staining. As could be expected, due to handling
and storage, the overall morphology weakened. DuoCISH
staining directly following BCL6-FISH staining, of an
unstained Euro-FISH TMA slide (cut, put on a glass slide
and stored for 1.5 years at 4°C), resulted in better overall
morphology; 24 cores (66.7%) out of 36 were scored as
“good”, 8 (22.2%) were scored as “intermediate”, 3 (8.3%)
as “poor/failure” and 1 (2.8) as “lost”. 
The BCL6 FISH probe was also used to test DuoCISH
staining on metaphase spreads made from B-lymphocytes
of healthy donors. Five metaphases were analyzed show-
ing that the probe localized to chromosome 3q27 (data not
shown).
While analyzing the hematoxylin counter-stain of the
DuoCISH-stained slides it emerged that the intensity of
this counter-stain is associated with the actual signal
intensity (Table 3). We, therefore, combined these two
datasets and showed that the intensity of the hematoxylin
signal corresponds to the signal strength. From our data
we conclude that strong hematoxylin and eosin back-
ground staining coincides with a strong signal; moderate
staining with a moderate signal; weak staining with a
weak signal and a failure of hematoxylin and eosin stain-
ing almost always results in a failure of signal intensity
(highest percentages per intensity are given and shown in
bold). 
Discussion
In this study we show that DuoCISH is a reliable and
good alternative to split-signal FISH staining. Comparing
the score, split or no split, resulting from the DuoCISH
procedure in this study to that in the EuroFISH program
(total of 310 cores), there were eight cores (2.58%) that
were differentially scored. During the Euro-FISH protocol
all TMA were scored in duplicate. TMA stained with the
same probe were stained and scored by separate laborato-
ries that had no prior knowledge of the results of the other
laboratory. Six of the eight CISH-stained cores with aber-
rant results consistently received the same score as the
duplicate FISH TMA. The results for two cores (0.65%)
were, however, inconsistent with those of both EuroFISH
duplicates, resulting in an overall consistency in score for
300 cores (96.77%). These results indicate that the inter-
pretation of CISH-stained samples is easier than that of
A. van Rijk et al.
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Table 2. Morphology of 540 cores that were scored during the Euro-FISH pro-
tocol (FISH) and 1.5 years later after CISH staining.
Morphology FISH DuoCISH
Total, n Percentage (%) Total, n Percentage (%)
Good 239 44.26% 66 12.22%
Intermediate 203 37.59% 268 49.63%
Poor/failure 71 13.15% 157 29.07%
Lost 27 5.00% 46 8.52%
No information 0 0.00% 0 0.00%
No score 0 0.00% 3 0.56%
Total 540 100.00% 540 100.00%
Table 3. DuoCISH signal intensity compared to the intensity of the hematoxylin and eosin (H&E) background staining. Highest number of CISH signal intensity and
corresponding background staining is given in bold. The percentage of the total number of screened cases is also calculated for these specific combinations.
CISH signal H&E background staining intensity
intensity good moderate weak very weak failure lost no score total, n
n (%) n (%) n (%) n (%) n (%) n (%) n (%)
No score 0 1 1 0 0 0 1 (0.2%) 3
Failure 1 11 24 54 (10.0%) 36 (6.7%) 0 0 126
Very weak 0 0 2 4 1 0 0 7
Weak 0 23 60 (11.1 %) 38 1 0 0 122
Moderate 16 94 (17.4%) 50 8 0 0 0 168
Strong 29 (5.4%) 37 8 1 0 0 0 75
Lost 0 0 0 0 0 39 (7.2%) 0 39
Total 46 166 145 105 38 39 1 540
FISH-stained ones, a finding that fits with the subjective
clinical impression of the people who evaluated the sam-
ples.
The results of this study show that the overall morphol-
ogy weakened after prolonged storage of split-signal FISH-
stained slides at 4°C. Although only one TMA with 36
cores was DuoCISH-stained directly following FISH, we
feel that, from a morphological point of view, it is better
to store the slides unstained. On the other hand if mor-
phology scores of “good” and “intermediate” (which
might be due to interpersonal variation in interpretation)
were considered together, the morphology scoring was
only 10% better during the Euro-FISH program.
It could, however, be argued that using old slides rather
than fresh re-cuts from the TMA blocks unnecessarily
complicated the study and that it decreased the number of
usable cores. It should, however, be kept in mind that the
availability of some tumor material is limited and, in some
cases, can be precious to use just to validate a technique.
We did, however, show that the freshly BCL6 FISH-
stained TMA performed better after CISH than the previ-
ously FISH-stained slides. Nevertheless, we think that re-
staining of “old” FISH-stained slides might, in certain cases
(referral or second opinion), be desirable.
Additionally we showed that although differences in
morphology, hematoxylin staining and CISH signal inten-
sity varied between the tumor entities, none of the entities
was easier or more difficult to score. During EuroFISH it
appeared that endemic Burkitt’s lymphoma, anaplastic
large cell lymphoma, lymphoplasmacytic lymphoma,
splenic marginal zone lymphoma, T-lymphoblastic lym-
phoma and reactive lesions resulted in approximately
88% reliable scores and B-cell chronic lymphocytic
leukemia/small lymphocytic lymphoma, diffuse large B-
cell lymphoma, follicular lymphoma, mantle cell lym-
phoma and sporadic Burkitt’s lymphoma in 90% reliable
scores, with the gastric MALT entity being the most diffi-
cult to score. Considering only the moderate and good
CISH signal intensities, B-cell chronic lymphocytic
leukemia/small lymphocytic lymphoma, reactive lesions,
diffuse large B-cell lymphoma and lymphoplasmacytic
lymphoma tumor samples had the best signal intensities
(with B-cell chronic lymphocytic leukemia/small lympho-
cytic lymphoma giving the strongest and lymphoplasma-
cytic lymphoma the weakest signal) and anaplastic large
cell lymphoma, follicular lymphoma, endemic Burkitt’s
lymphoma and MALT lymphoma were the four weakest
stained samples (with anaplastic large cell lymphoma the
weakest and MALT the strongest). We, therefore, con-
clude that although FISH and CISH signals are generally
comparable, a difficult-to-read split-signal FISH does not
necessarily result in a weak CISH signal. Furthermore, it is
DuoCISH as an alternative to split-signal FISH
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Figure 2. Mantle cell lym-
phoma tissue (1 core of
a TMA with 36 cores)
stained with (A) a CCDN1
split-signal probe during
the Euro-FISH program
(FITC- and Texas-Red
labeled) and 1.5 year
later (B) with the
DuoCISH procedure (blue
and red chromogen sig-
nals). (A) Leica micro-
scope DM4000B, magni-
fication 400x, colors cor-
rected and clipping of the
image after acquisition
with Adobe Photoshop.
(B) Zeiss Axioskop 2 plus
microscope, magnifica-
tion 400x, colors correct-
ed and clipping of the
image after acquisition
with Adobe Photoshop.
very relevant that hematoxylin background staining inten-
sity correlates with signal intensity, because it makes rou-
tine application of the procedure less dependent on stain-
ing variables.
In conclusion, we show, importantly for routine applica-
tion, that split-signal DuoCISH is at least as reliable as
split-signal FISH, a well-documented method for detecting
chromosomal breaks in lymphoma samples. Since CISH
can be performed in all pathology laboratories on routine
samples, our findings suggest that this method could facil-
itate the classification of lymphomas. 
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